Supernus Pharmaceuticals (SUPN) PT Raised to $40 at Cowen
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Price: $47.15 -1.5%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Cowen analyst Ken Cacciatore raised the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $40.00 (from $35.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Sampo Oyj (SAMPO:FH) (SAXPY) PT Raised to EUR11.20 at Berenberg
- Azelis Group NV (AZE:BB) PT Raised to EUR13 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
